"A drug that combines four different medicines and could halve deaths from heart attacks and stroke around the globe will enter human trials this week in London. The once-a-day polypill has been the dream of doctors for many years, but because the drugs it contains, including aspirin, are cheap, there has been no financial incentive for the pharmaceutical industry to get involved. Now, however, international teams of researchers, with the backing in the UK of the Wellcome Trust and the British Heart Foundation, are just a few years away from making the polypill an accessible reality" - GuardianThis is the blog for CARG, the Coronary Artery Rehabilitation Group, based in Saskatoon, Saskatchewan, Canada. It will contain items of interest to CARG's own members and anybody else interested in the latest news about rehabilitation and heart-related matters. Canadian charitable number: 89675 0163 RR 0001 || e-mail: carg.ca@gmail.com || website: carg.ca || Blog disclaimer
Monday, September 29, 2008
Tests start on pill that could lengthen millions of lives
"A drug that combines four different medicines and could halve deaths from heart attacks and stroke around the globe will enter human trials this week in London. The once-a-day polypill has been the dream of doctors for many years, but because the drugs it contains, including aspirin, are cheap, there has been no financial incentive for the pharmaceutical industry to get involved. Now, however, international teams of researchers, with the backing in the UK of the Wellcome Trust and the British Heart Foundation, are just a few years away from making the polypill an accessible reality" - Guardian
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment